Clinical Trial Update: Efficacy of Totalfill® and ProRoot MTA® as Pulpotomy Agent in Primary Molars [Phase 4]

View source ↗

Summary

Phase 4 trial updating the efficacy of Totalfill and ProRoot MTA as pulpotomy agents in extensively decayed primary molars.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensively Decayed Primary Molars

Drugs mentioned

• ProRoot MTA (mineral trioxide aggregate)
• Totalfill

Snippet

Sponsor: University Ghent | Conditions: Extensively Decayed Primary Molars | Phase 4 | Status: COMPLETED